Congenital bronchiectasis
ICD-10 Q33.4 is a billable code used to indicate a diagnosis of congenital bronchiectasis.
Congenital bronchiectasis is a rare respiratory condition characterized by the abnormal dilation of the bronchi, which can lead to chronic respiratory infections and impaired lung function. This condition is often associated with other congenital malformations of the respiratory system, such as choanal atresia, tracheoesophageal fistula, and lung hypoplasia. In infants, bronchiectasis may result from developmental anomalies that disrupt normal airway structure and function. The condition can manifest with symptoms such as chronic cough, wheezing, and recurrent pneumonia. Diagnosis typically involves imaging studies, such as chest X-rays or CT scans, which reveal the characteristic bronchial dilation. Management may include antibiotics for infections, airway clearance techniques, and in severe cases, surgical intervention. Understanding the underlying congenital factors is crucial for effective treatment and long-term management of affected children.
Detailed history of respiratory symptoms, family history of congenital conditions, and results of imaging studies.
Infants presenting with recurrent respiratory infections, chronic cough, or wheezing.
Consideration of developmental milestones and the impact of respiratory conditions on growth and development.
Genetic testing results, family pedigree, and documentation of any syndromic associations.
Cases where bronchiectasis is part of a genetic syndrome or associated with chromosomal abnormalities.
Understanding the genetic basis of congenital malformations and their implications for family planning.
Used in conjunction with bronchiectasis management to improve lung function.
Document the need for rehabilitation based on respiratory assessment.
Pediatric specialists may need to tailor rehabilitation programs for younger patients.
Accurate coding of congenital bronchiectasis is crucial for appropriate management, treatment planning, and ensuring that patients receive the necessary care. It also impacts healthcare reimbursement and the tracking of congenital conditions in pediatric populations.
